Loading clinical trials...
Loading clinical trials...
Finerenone Research of Outcomes and Drug Utilization
Conditions
Interventions
Finerenone (BAY 94-8862)
Locations
4
United States
Many Locations
Multiple Locations, New Jersey, United States
Bayer
Berlin, Germany
Many Locations
Multiple Locations, Japan
Many Locations
Multiple Locations, Taiwan
Start Date
May 15, 2024
Primary Completion Date
September 30, 2026
Completion Date
September 30, 2026
Last Updated
March 31, 2026
NCT07547098
NCT07493642
NCT07051005
NCT07241390
NCT06926660
NCT05728216
Lead Sponsor
Bayer
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions